APA (7th ed.) Citation

TB, C., YT, Y., LN, S., YJ, G., & YQ, W. (2026). Zanubrutinib in B-cell lymphomas: From clinical pharmacology to therapeutic application. European journal of clinical pharmacology, 82(2), 54. https://doi.org/10.1007/s00228-025-03987-4

Chicago Style (17th ed.) Citation

TB, Chen, Yan YT, Sun LN, Guo YJ, and Wang YQ. "Zanubrutinib in B-cell Lymphomas: From Clinical Pharmacology to Therapeutic Application." European Journal of Clinical Pharmacology 82, no. 2 (2026): 54. https://doi.org/10.1007/s00228-025-03987-4.

MLA (9th ed.) Citation

TB, Chen, et al. "Zanubrutinib in B-cell Lymphomas: From Clinical Pharmacology to Therapeutic Application." European Journal of Clinical Pharmacology, vol. 82, no. 2, 2026, p. 54, https://doi.org/10.1007/s00228-025-03987-4.